IMMUNECYTE
ImmuneCyte is a multilingual, clinical-stage biopharmaceutical firm dedicated to the study and creation of alternative cell and gene medicines, such as CAR-NK, mononuclear, and T cells with chimeric antigen receptors, for the treatment of cancer, vascular, orthopaedic, and age-related illnesses. They have developed technological cell-based gene treatments on this platform to treat severe cases of b-thalassemia, a fatal blood genetic condition.
IMMUNECYTE
Industry:
Biotechnology Life Science Therapeutics Wellness
Founded:
2015-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.immunecyte.com
Total Employee:
51+
Status:
Active
Contact:
+1 800 797 6330
Email Addresses:
[email protected]
Technology used in webpage:
SPF Gravatar Profiles Unified Layer
Official Site Inspections
http://www.immunecyte.com
- Host name: 192-185-16-47.unifiedlayer.com
- IP address: 192.185.16.47
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "ImmuneCyte"
ImmuneCyte - Crunchbase Company Profile & Funding
ImmuneCyte is a multilingual, clinical-stage biopharmaceutical firm dedicated to the study and creation of alternative cell and gene medicines, such as CAR-NK, mononuclear, and T cells …See details»
ImmuneCyte, Inc. - The Org
ImmuneCyte is a multilingual, clinical-stage biopharmaceutical firm dedicated to the study and creation of alternative cell and gene medicines, such as CAR-NK, mononuclear, and T cells …See details»
ImmuneCyte - VentureRadar
" ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research and development of innovative cell and gene therapeutics, including chimeric antigen receptor …See details»
Cesca Therapeutics And HealthBanks Biotech (USA) Enter Immune …
Oct 29, 2019 The joint venture will be named ImmuneCyte Life Sciences Inc. (“ImmuneCyte”) and is expected to officially launch during the fourth quarter of 2019. Cesca Therapeutics Inc., …See details»
Immunecyte, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Immunecyte, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Hemic and Lymphatic Diseases, Immune System ...See details»
ImmuneCyte, Inc. - LinkedIn
ImmuneCyte, Inc. | 491 followers on LinkedIn. A HealthBanks Biotech Company | ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research and …See details»
ImmuneCyte Inc. Company Profile | Irvine, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ImmuneCyte Inc. of Irvine, CA. Get the latest business insights from Dun & Bradstreet.See details»
ImmuneCyte Life Sciences - Products, Competitors, Financials, …
Apr 13, 2020 ImmuneCyte Life Sciences is a clinical-stage biopharmaceutical company focused on developing innovative cell and gene therapeutics for the treatment of cancer, vascular, …See details»
ImmuneCyte - Crunchbase
ImmuneCyte develops cell and gene therapeutics for the aging-related diseasesSee details»
ImmuneCyte Life Sciences, Inc. - CMOCRO
ImmuneCyte develops and commercializes immunological products and services. The company provides clients the opportunity to bank their own immune cells when the cells are “healthy …See details»
ImmuneCyte - Contacts, Employees, Board Members, Advisors
Organization. ImmuneCyte . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. ImmuneCyte has 1 current …See details»
ImmuneCyte acquires rights to antibody drug candidates for …
Apr 13, 2020 ImmuneCyte Life Sciences Inc. said the company completed an acquisition of certain technologies to develop antibody therapies for COVID-19. ImmuneCyte, which is a joint …See details»
ImmuneCyte Life Sciences - PitchBook
ImmuneCyte Life Sciences is headquartered in Irvine, CA. What industry is ImmuneCyte Life Sciences in? ImmuneCyte Life Sciences’s primary industry is Other Pharmaceuticals and …See details»
ThermoGenesis Holdings Announces That ImmuneCyte Joint
RANCHO CORDOVA, Calif., Jan. 3, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell …See details»
ImmuneCyte - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ImmuneCyte develops cell and gene therapeutics for the aging-related diseasesSee details»
ThermoGenesis Announces That Results of ImmuneCyte's Licensed ...
Jun 8, 2020 ImmuneCyte Life Sciences, Inc., is a joint venture which is 19% owned by ThermoGenesis. ImmuneCyte develops various immunological products and services and …See details»
ThermoGenesis Announces Its ImmuneCyte Joint Venture Acquires …
Apr 13, 2020 ImmuneCyte, a joint venture which is 19% owned by ThermoGenesis, is one of the first U.S. based immune cell banks to develop and commercialize immunological products and …See details»
ImmuneCyte - Facebook
ImmuneCyte. 13 likes. ImmuneCyte is creating revolutionary innovations in the field of immune cell banking. By preserving immune cells while a person is still young and healthy, they set …See details»
IMC 2019 - AdisInsight - Springer
IMC 2019 is a cell therapy being developed by Immunecyte (is a joint venture between HealthBanks Biotech (USA) and ThermoGenesis) by using its AutoSTEM platform ... If your …See details»
Immunecyte, Inc. (Immunecyte, Inc.) - 药物管线_专利_临床试验_投 …
了解Immunecyte, Inc. (Immunecyte, Inc.)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:肿瘤，血液及淋巴系统疾病，免疫系统疾病，内分泌与代谢疾病，神经系统疾病，技术 …See details»